Stefan Monig
Overview
Explore the profile of Stefan Monig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1986
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mechahougui H, Chevallay M, Cauchy F, Chaveau N, Puppa G, Koessler T, et al.
Front Oncol
. 2024 Dec;
14:1440046.
PMID: 39634260
Gastric cancer often presents at an advanced stage in Western populations due to a lack of screening programs, leading to poor prognoses. Historically, palliative chemotherapy resulted in a median survival...
2.
Herrera Kok J, Marano L, van den Berg J, Shetty P, Vashist Y, Lorenzon L, et al.
Eur J Surg Oncol
. 2024 May;
50(7):108387.
PMID: 38796969
Gastro-oEsophageal Cancers (GECs) are severe diseases whose management is rapidly evolving. The European Society of Surgical Oncology (ESSO) is committed to the generation and spread of knowledge, and promotes the...
3.
Kroese T, Bronzwaer S, van Rossum P, Schoppman S, Deseyne P, Van Cutsem E, et al.
Eur J Cancer
. 2024 Apr;
204:114062.
PMID: 38678762
Introduction: The OligoMetastatic Esophagogastric Cancer (OMEC) project aims to provide clinical practice guidelines for the definition, diagnosis, and treatment of esophagogastric oligometastatic disease (OMD). Methods: Guidelines were developed according to...
4.
Kroese T, van Laarhoven H, Schoppman S, Deseyne P, Van Cutsem E, Haustermans K, et al.
Eur J Cancer
. 2023 Mar;
185:28-39.
PMID: 36947929
Background: Local treatment improves the outcomes for oligometastatic disease (OMD, i.e. an intermediate state between locoregional and widespread disseminated disease). However, consensus about the definition, diagnosis and treatment of oligometastatic...
5.
Maillard J, Elia N, Ris F, Courvoisier D, Zekry D, Labidi Galy I, et al.
BMJ Open
. 2023 Feb;
13(2):e065902.
PMID: 36813502
Introduction: Postoperative health-related quality of life (HRQoL) is an essential outcome in oncological surgery, particularly for elderly patients undergoing high-risk surgery. Previous studies have suggested that, on average, HRQoL returns...
6.
Nickel F, Studier-Fischer A, Hausmann D, Klotz R, Vogel-Adigozalov S, Tenckhoff S, et al.
BMJ Open
. 2022 Oct;
12(10):e064286.
PMID: 36316075
Introduction: The only curative treatment for most gastric cancer is radical gastrectomy with D2 lymphadenectomy (LAD). Minimally invasive total gastrectomy (MIG) aims to reduce postoperative morbidity, but its use has...
7.
Chevallay M, Wassmer C, Bonino M, Monig S
Transl Gastroenterol Hepatol
. 2022 Mar;
7:13.
PMID: 35243122
No abstract available.
8.
Kroese T, van Hillegersberg R, Schoppmann S, Deseyne P, Nafteux P, Obermannova R, et al.
Eur J Cancer
. 2022 Feb;
164:18-29.
PMID: 35134666
Background: Consensus about the definition and treatment of oligometastatic oesophagogastric cancer is lacking. Objective: To assess the definition and treatment of oligometastatic oesophagogastric cancer across multidisciplinary tumour boards (MDTs) in...
9.
Giudicelli G, Poletti P, Platon A, Marescaux J, Vix M, Diana M, et al.
Ann Surg
. 2020 Oct;
275(6):1137-1142.
PMID: 33074896
Objective: The aim of this study was to develop and validate a prediction score for internal hernia (IH) after Roux-en-Y gastric bypass (RYGB). Summary Background Data: The clinical diagnosis of...
10.
Chevallay M, Jung M, Chon S, Takeda F, Akiyama J, Monig S
Ann N Y Acad Sci
. 2020 Sep;
1482(1):146-162.
PMID: 32935342
Esophagectomy, even with the progress in surgical technique and perioperative management, is a highly specialized surgery, associated with a high rate of complications. Early recognition and adequate treatment should be...